Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | PYGB | P11216 | 1/20 | 0.45 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.44 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.44 |
| ▸ | IGF2R | P11717 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29217353 | 1.00 | L3MBTL1 (0.47) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL9684872 | 1.00 | L3MBTL1 (0.47) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL28453332 | 1.00 | L3MBTL1 (0.47) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL11216298 | 1.00 | L3MBTL1 (0.47) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL28790781 | 0.98 | LGALS8 (0.46) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL9559641 | 0.98 | LGALS8 (0.46) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL9559995 | 0.98 | LGALS8 (0.46) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL8994862 | 0.87 | LGALS3 (0.53) | TYRPTPN1LGALS8IGF2R | |
| SCHEMBL28902343 | 0.86 | PYGB (0.50) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL28453329 | 0.86 | PYGB (0.50) | L3MBTL1GAATYRMAPTPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111712507-A | Method for improving oral bioavailability of drugs | 药物有限公司 | 2020-09-25 | — | — | CN | disclosed |